QUMAS Announces The Launch Of A New Biotechnology Package For Growing Biotech Organizations
September 15, 2009
QUMAS, the leading provider of Compliance Solutions to in a high degree. regulated industries, announced the throw of the QUMAS Biotechnology Package, a complete web-based electronic document management scheme (eDMS) for Biotechnology companies preparing towards regulatory forbearance. This affordable package has been created specifically for small biotech companies, in order to bestow them access to QUMAS DocCompliance, the leading eDMS used by series one companies globally. Growing biotechs can since afford a complete eDMS for document mastery, which is preconfigured with industry practices, and can be validated and live within 30 days.
“We are delighted to be able to provide some affordable offering to smaller companies who can a little while ago leverage the same solutions as the leaders in their space in a require to be paid effective and highly cause package,” related Ken Hayward, CTO of QUMAS. “They can also purchase our expertise, as configured in the system, to ensure that they have influence a compliant organization from the outset, fabrication them more viable in a regulatory context and more attractive to investors and partners.”
The QUMAS Biotechnology package is:
— Easy and fast to implement — go live within 30 days
— Pre-configured with industry standards for regulatory concession
— Best of breed document management, which is in used in too 250 facilities globally
— Extendable and scalable, for the reason that the visitor, the requirements and the infrastructures grow
— Easy to employment with fast course training built in
— Compatible with all existing documents and processes
— A cost effective terraqueous globe rank disunion at an industry governing cost
QUMAS is launching the Biotechnology Package in the EU in succession September 15, at the DMS Expo in Cologne. QUMAS is launching the Biotechnology Package in the US on September 16, at a Compliance Breakfast Seminar in the Vertex Pharmaceuticals facility in Cambridge, MA. Also speaking at this event will be clients from Vertex Pharmaceuticals and Millennium Pharmaceuticals, along with QUMAS Regulatory experts.
Source
QUMAS

